Alnylam Pharmaceuticals
ALNY
#650
Rank
HK$235.03 B
Marketcap
HK$1,822
Share price
0.28%
Change (1 day)
21.34%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company